A combined theoretical and in vitro modeling approach for predicting the magnetic capture and retention of magnetic nanoparticles in vivo.

Magnetic nanoparticles (MNP) continue to draw considerable attention as potential diagnostic and therapeutic tools in the fight against cancer. Although many interacting forces present themselves during magnetic targeting of MNP to tumors, most theoretical considerations of this process ignore all except for the magnetic and drag forces. Our validation of a simple in vitro model against in vivo data, and subsequent reproduction of the in vitro results with a theoretical model indicated that these two forces do indeed dominate the magnetic capture of MNP. However, because nanoparticles can be subject to aggregation, and large MNP experience an increased magnetic force, the effects of surface forces on MNP stability cannot be ignored. We accounted for the aggregating surface forces simply by measuring the size of MNP retained from flow by magnetic fields, and utilized this size in the mathematical model. This presumably accounted for all particle-particle interactions, including those between magnetic dipoles. Thus, our "corrected" mathematical model provided a reasonable estimate of not only fractional MNP retention, but also predicted the regions of accumulation in a simulated capillary. Furthermore, the model was also utilized to calculate the effects of MNP size and spatial location, relative to the magnet, on targeting of MNPs to tumors. This combination of an in vitro model with a theoretical model could potentially assist with parametric evaluations of magnetic targeting, and enable rapid enhancement and optimization of magnetic targeting methodologies.

[1]  C. Driscoll,et al.  Magnetic targeting of microspheres in blood flow. , 1984, Microvascular research.

[2]  J. Laterra,et al.  Endothelial differentiation in intracerebral and subcutaneous experimental gliomas , 1994, Brain Research.

[3]  Q. Pankhurst,et al.  Applications of magnetic nanoparticles in biomedicine , 2003 .

[4]  Ralph Weissleder,et al.  Multifunctional magnetic nanoparticles for targeted imaging and therapy. , 2008, Advanced drug delivery reviews.

[5]  Igor Katsyv,et al.  Experimental approaches for the treatment of malignant gliomas. , 2010, Pharmacology & therapeutics.

[6]  H. Maeda,et al.  Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[7]  Yongzhuo Huang,et al.  Glioma selectivity of magnetically targeted nanoparticles: a role of abnormal tumor hydrodynamics. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[8]  A P Pathak,et al.  MR‐derived cerebral blood volume maps: Issues regarding histological validation and assessment of tumor angiogenesis , 2001, Magnetic resonance in medicine.

[9]  J. Kreuter,et al.  Significant Transport of Doxorubicin into the Brain with Polysorbate 80-Coated Nanoparticles , 1999, Pharmaceutical Research.

[10]  J. Dobson Magnetic nanoparticles for drug delivery , 2006 .

[11]  Christian Bergemann,et al.  Iron oxide nanoparticles as a drug delivery vehicle for MRI monitored magnetic targeting of brain tumors. , 2008, Biomaterials.

[12]  K. Geiger,et al.  Chemotherapy of glioblastoma in rats using doxorubicin‐loaded nanoparticles , 2004, International journal of cancer.

[13]  T. Weyh,et al.  Design and Evaluation of Magnetic Fields for Nanoparticle Drug Targeting in Cancer , 2007, IEEE Transactions on Nanotechnology.

[14]  C. Alexiou,et al.  A High Field Gradient Magnet for Magnetic Drug Targeting , 2006, IEEE Transactions on Applied Superconductivity.

[15]  M. Garwood,et al.  Imaging blood flow in brain tumors using arterial spin labeling , 2000, Magnetic resonance in medicine.

[16]  James L. McGrath,et al.  The influence of protein adsorption on nanoparticle association with cultured endothelial cells. , 2009, Biomaterials.

[17]  F. Stenger,et al.  Control of aggregation in production and handling of nanoparticles , 2005 .

[18]  Victor C Yang,et al.  Polyethyleneimine-modified iron oxide nanoparticles for brain tumor drug delivery using magnetic targeting and intra-carotid administration. , 2010, Biomaterials.

[19]  C. Bárcena,et al.  APPLICATIONS OF MAGNETIC NANOPARTICLES IN BIOMEDICINE , 2003 .

[20]  Renwei Mei,et al.  Shear lift force on spherical bubbles , 1994 .

[21]  B. Moffat,et al.  Substantiating in vivo magnetic brain tumor targeting of cationic iron oxide nanocarriers via adsorptive surface masking. , 2009, Biomaterials.

[22]  P A Voltairas,et al.  Hydrodynamics of magnetic drug targeting. , 2002, Journal of biomechanics.

[23]  M. Menger,et al.  Vascular Microenvironment in Gliomas , 2000, Journal of Neuro-Oncology.

[24]  Wang Shi-gang,et al.  Hydrodynamic modeling of ferrofluid flow in magnetic targeting drug delivery , 2008 .

[25]  P Reichardt,et al.  Clinical experiences with magnetic drug targeting: a phase I study with 4'-epidoxorubicin in 14 patients with advanced solid tumors. , 1996, Cancer research.

[26]  V. Yang,et al.  Magnetically-enabled and MR-monitored selective brain tumor protein delivery in rats via magnetic nanocarriers. , 2011, Biomaterials.